J. Goldman & Co LP
- SEC CIK
- 0001412741
- Latest filing
- Aug 14, 2026
ITOS holding history
iTeos Therapeutics, Inc. in every 13F filed by J. Goldman & Co LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITOS overviewAll 13F holders of ITOSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −34,367−100.0% | Sold out | Holders |
| Q3 2024 | 34,367 | $350.9K | <0.1% | −35,218−50.6% | Reduced | Holders |
| Q2 2024 | 69,585 | $1.03M | <0.1% | −12,568−15.3% | Reduced | Holders |
| Q1 2024 | 82,153 | $1.12M | 0.1% | +82,153 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −42,110−100.0% | Sold out | Holders |
| Q1 2021 | 42,110 | $1.44M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.